Fastende plasmaglucose er enten lig med eller lavere hos patienter, der behandles med EXUBERA sammenlignet med patienter, der udelukkende behandles Læ
Fasting plasma glucose was similar n to or lower in patients using a regimen including EXUBERA compared to patients treated with oral agents alone.